Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;67(9):e28541.
doi: 10.1002/pbc.28541. Epub 2020 Jun 23.

How we infuse blinatumomab

Katelyn Oranges  1 , Sarah Windawi  1 , Stephanie Powell  1 , David Dallago  2 , Nicole Escobar  1 , Susan R Rheingold  1
Affiliations

How we infuse blinatumomab

Katelyn Oranges et al. Pediatr Blood Cancer. 2020 Sep.
No abstract available

Keywords: acute lymphoblastic leukemia; blinatumomab; continuous infusion; immunotherapy; pediatrics; relapse.

PubMed Disclaimer

References

REFERENCES

    1. von Stackelberg A, Locatelli F, Zugmaier G, et al. Phase I/Phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia. J Clin Oncol. 2016;34(36):4381-4389.
    1. Jaffray J, Witmer C, O'Brien SH, et al. Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children. Blood. 2020;135(3):220-226.
    1. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer. 2008;51(1):53-58.
    1. Hord J, Lawlor J, Werner E, et al. Central line associated blood stream infections in pediatric hematology/oncology patients with different types of central lines. Pediatr Blood Cancer. 2016;63(9):1603-1607.
    1. Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood. 2013;121(26):5154-5147.

MeSH terms

LinkOut - more resources